Colgate-Palmolive (NYSE:CL) hit a new 52-week high on Monday . The company traded as high as $70.06 and last traded at $69.45, with a volume of 192703 shares changing hands. The stock had previously closed at $69.35.
A number of equities research analysts have recently weighed in on the stock. Zacks Investment Research lowered shares of Colgate-Palmolive from a “buy” rating to a “sell” rating in a report on Monday, April 15th. Citigroup set a $68.00 price objective on shares of Colgate-Palmolive and gave the company a “hold” rating in a report on Tuesday, March 19th. UBS Group increased their target price on shares of Colgate-Palmolive from $71.00 to $75.00 and gave the company a “buy” rating in a research report on Friday, March 29th. Macquarie set a $57.00 target price on shares of Colgate-Palmolive and gave the company a “hold” rating in a research report on Tuesday, January 29th. Finally, Credit Suisse Group started coverage on shares of Colgate-Palmolive in a research report on Wednesday, March 6th. They issued an “underperform” rating on the stock. Three research analysts have rated the stock with a sell rating, twelve have given a hold rating and four have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $65.73.
The company has a debt-to-equity ratio of 32.25, a quick ratio of 0.76 and a current ratio of 1.14. The stock has a market cap of $59.63 billion, a P/E ratio of 23.24, a price-to-earnings-growth ratio of 4.55 and a beta of 0.79.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a dividend of $0.43 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 annualized dividend and a yield of 2.49%. The ex-dividend date is Wednesday, April 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.91%.
In other Colgate-Palmolive news, CEO Ian M. Cook sold 22,634 shares of the firm’s stock in a transaction on Tuesday, February 19th. The shares were sold at an average price of $66.31, for a total transaction of $1,500,860.54. Following the transaction, the chief executive officer now directly owns 1,162,793 shares of the company’s stock, valued at approximately $77,104,803.83. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John T. Cahill sold 5,780 shares of the firm’s stock in a transaction on Thursday, January 31st. The stock was sold at an average price of $64.46, for a total transaction of $372,578.80. Following the transaction, the director now directly owns 27,820 shares in the company, valued at $1,793,277.20. The disclosure for this sale can be found here. Insiders have sold a total of 103,200 shares of company stock worth $6,900,449 over the last three months. 1.14% of the stock is currently owned by insiders.
A number of institutional investors have recently modified their holdings of the business. Bristlecone Advisors LLC grew its position in Colgate-Palmolive by 2.6% during the 1st quarter. Bristlecone Advisors LLC now owns 23,402 shares of the company’s stock worth $1,604,000 after purchasing an additional 585 shares during the last quarter. Winthrop Advisory Group LLC purchased a new position in Colgate-Palmolive during the 1st quarter worth $233,000. Creative Financial Designs Inc. ADV purchased a new position in Colgate-Palmolive during the 1st quarter worth $157,000. Mercer Global Advisors Inc. ADV purchased a new position in Colgate-Palmolive during the 1st quarter worth $3,120,000. Finally, Lindbrook Capital LLC grew its position in Colgate-Palmolive by 32.8% during the 1st quarter. Lindbrook Capital LLC now owns 818 shares of the company’s stock worth $56,000 after purchasing an additional 202 shares during the last quarter. 76.27% of the stock is currently owned by institutional investors.
About Colgate-Palmolive (NYSE:CL)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Read More: Special Dividends
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.